Comparator Drug Sourcing: The Benefits of Taking a Strategic Approach (Podcast)

Mar 30, 2009
By Applied Clinical Trials Editors

Comparator Drug Sourcing – The Benefits of Taking a Strategic Approach

Mark Ware

Add this Podcast feed to your media player

Join Applied Clinical Trials, Editor in Chief Lisa Henderson and Director of Clinical Trial Services, Mark Ware from IDIS as they discuss comparator sourcing with strategic and tactical approaches.

This podcast will discuss how procurement teams charged with sourcing comparator drugs for clinical trials can move from a tactical sourcing approach to a strategic approach that will reduce the likelihood of an unreliable supply of comparator, reduce the chance of unnecessary delays in the trial, and reduce unplanned costs.

Download additional information about comparator sourcing at

IDIS develops and executes comparator sourcing strategies that deliver the right comparator at the right time – throughout the course of a clinical trial, while minimizing the sponsor’s exposure to the operational, regulatory and financial risks that can often accompany comparator sourcing. To meet clients’ global comparator requirements, IDIS integrates four key disciplines in the development of customized sourcing strategies: global sourcing capabilities, direct manufacturer relationships, extensive regulatory expertise, and global distribution capabilities.